| Quark Signs $680M siRNA Drug Deal with Novartis - BioWorld Online |
|
|
BioWorld OnlineRenal failure serious enough to warrant temporary dialysis occurs in up to 2 percent of open heart surgery patients, according to the Cleveland Clinic ... read more |